On the HCPLive news page, resources on the topics of disease- and specialty-specific medical news and expert insight can be found. Content includes articles, interviews, videos, podcasts, and breaking news on health care research, treatment, and drug development.
Patients with Rheumatoid Arthritis Satisfied with Switch to Adalimumab Biosimilar
Results of the study, which focused on patient-reported outcomes in addition to clinical measurements, mirror findings from other large-scale studies evaluating the safety and efficacy of biosimilars in patients with rheumatoid arthritis.
SGLT2 Inhibitors Can Aid Weight Loss, Reduce Fat Mass in People with Type 2 Diabetes
January 7th 2023Using data from 18 trials with more than 1400 participants, a systematic review and meta-analysis offer clinicians an overview of the effects of SGLT2 inhibitor use on body composition in people with type 2 diabetes.
Heart Failure Risk Stratification Benefited Clinical Decision Making in Emergency Department
January 7th 2023The COACH trial reported a hospital-based strategy led to lower risk of death from any cause or hospitalization for cardiovascular causes within 30 days than usual care in patients with acute heart failure.
TNFi Treatment did not Increase Incidence of Hematological Malignancies in Psoriatic Arthritis
Although the incidence rates were similar among those treated with TNFi and biologics-naïve patients, patients with psoriatic arthritis had a 35% increased risk when compared with the general population.
More Than 1-in-4 Cardiologists Report Mental Health Conditions, Survey Finds
January 6th 2023Data from a 2019 survey of more than 5000 cardiologists across the globe suggests 28% of the field may be experiencing some form of mental health condition, with results also shedding light on predictors of mental health conditions.
SGLT2 Inhibitors Can Reduce Cardiometabolic Risk in People with Diabetes Using Metformin
January 6th 2023Using data from more than 55,000 people with diabetes using metformin is providing new insight into the apparent reductions in risk of negative cardiovascular and renal outcomes as well as all-cause mortality with use of SGLT2 inhibitors.
Study Raises Concerns Over Increasing BMI, Obesity in Preschool-Aged Children During Pandemic
January 5th 2023Using data from more than 25,000 preschool-aged children in Sweden provides an overview in trends of weight gain and BMI changes that may have impacted pediatric populations during the COVID-19 pandemic.
EVOLUTION HF Provides Overview of Global Trends in GDMT Use for Heart Failure
January 5th 2023Using real-world data from the US, Japan, and Sweden provides insight into contemporary trends in GDMT use, including initiation, uptitration, and discontinuation, following hospitalization among patients with heart failure with reduced ejection fraction.